Palvella Therapeutics
PVLA
92 hedge funds and large institutions have $99M invested in Palvella Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 13 closing their positions.
6% more capital invested
Capital invested by funds: $93M → $99M (+$5.96M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.46% less ownership
Funds ownership: 64.58% → 60.12% (-4.5%)
6% less funds holding
Funds holding: 98 → 92 (-6)
27% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 30
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TA
Teachers Advisors
New York
|
+$1.21M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$498K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$436K |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$393K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$331K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$10.1M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.86M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.07M |
| 4 |
Millennium Management
New York
|
-$1.06M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$885K |
PVLA Hedge Fund Activity: Q1 2019 in Review
92 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q1 2019, worth a combined $99M — up 6.4% from $93M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PVLA and 7 opened new positions — a net loss of 6 holders — while 30 trimmed existing stakes and 22 added.
The largest buyer was Teachers Advisors, adding an estimated $1.21M. The largest seller was BVF Inc, cutting an estimated $10.1M.
- 92 institutional investors held Palvella Therapeutics (PVLA) as of Q1 2019, down from 98 in Q4 2018.
- Funds reported $99M of Palvella Therapeutics stock for Q1 2019, up 6.4% quarter-over-quarter.
- 7 funds opened new Palvella Therapeutics positions in Q1 2019 and 13 closed out, a net change of -6 holders.
- The largest Palvella Therapeutics buyer in Q1 2019 was Teachers Advisors, an estimated $1.21M added.
- The largest Palvella Therapeutics seller in Q1 2019 was BVF Inc, an estimated $10.1M sold.
Based on aggregated 13F filings for Q1 2019.